MONACO, LAVINIA

MONACO, LAVINIA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.01 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 01 - Articolo su rivista 2020 Crivellaro, CinziaLandoni, ClaudioBuda, AlessandroBonacina, ManuelaGrassi, TommasoMonaco, LaviniaGiuliani, DanielaGotuzzo, IreneMagni, SoniaDi Martino, GiampaoloDelle Marchette, MartinaGuerra, LucaLandoni, FabioFruscio, RobertMessa, CristinaDe Bernardi, Elisabetta +
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 01 - Articolo su rivista 2021 Monaco, LaviniaCrivellaro, CinziaFoti, GiuseppeLandoni, ClaudioMessa, CristinaGuerra, Luca +
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 01 - Articolo su rivista 2021 Monaco L.Gotuzzo I.Crivellaro C.Cortinovis D.Bernasconi D. P.Guerra L. +
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 01 - Articolo su rivista 2022 Monaco, LMathoux, GPresotto, LMangili, GCioffi, RMapelli, P +
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 01 - Articolo su rivista 2022 Monaco, LaviniaDe Bernardi, ElisabettaCortinovis, DiegoCrivellaro, CinziaL'Imperio, VincenzoLandoni, ClaudioMathoux, GregoryPagni, FabioTurolla, Elia AnnaMessa, CristinaGuerra, Luca +
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 01 - Articolo su rivista 2022 De Ponti, ElenaCrivellaro, CinziaMorzenti, SabrinaMonaco, LaviniaTodde, SergioLandoni, ClaudioGuerra, Luca +
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 02 - Intervento a convegno 2023 Gotuzzo, ICazzaniga, MDe Bernardi, ECicchiello, FCordani, NCerrito, MTurolla, ELandoni, CCrivellaro, CVirdone, LMonaco, LGuerra, L +